BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10335663)

  • 1. Changes in ds/dn in the HIV-1 env gene.
    Nielsen R
    Mol Biol Evol; 1999 May; 16(5):711-4. PubMed ID: 10335663
    [No Abstract]   [Full Text] [Related]  

  • 2. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.
    Hunt JC; Golden AM; Lund JK; Gürtler LG; Zekeng L; Obiang J; Kaptué L; Hampl H; Vallari A; Devare SG
    AIDS Res Hum Retroviruses; 1997 Aug; 13(12):995-1005. PubMed ID: 9264286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV evolutionary genetics.
    Rodrigo AG
    Proc Natl Acad Sci U S A; 1999 Sep; 96(19):10559-61. PubMed ID: 10485860
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification and characterization of previously described epitopes in HIV-1 subtypes B, C, F and BF in Brazil.
    Queiroz AT; Santos LA; Moreau DR; Oliveira Td; Watkins DI; Galvão-Castro B; Alcantara LC
    Braz J Infect Dis; 2007 Feb; 11(1):27-30. PubMed ID: 17625722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV type 1 env gene diversity detected in Taiwan.
    Chang KS; Lin CI; Chen JH; Shih CH; Lin HC; Lin RY; Twu SC; Salminen MO
    AIDS Res Hum Retroviruses; 1997 Jan; 13(2):201-4. PubMed ID: 9007206
    [No Abstract]   [Full Text] [Related]  

  • 6. Second site escape of a T20-dependent HIV-1 variant by a single amino acid change in the CD4 binding region of the envelope glycoprotein.
    Baldwin CE; Berkhout B
    Retrovirology; 2006 Nov; 3():84. PubMed ID: 17134507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodiversity and bioseparation of HIV-1 envelope glycoproteins.
    Shao Y; Lu Y
    Crit Rev Oncog; 1999; 10(1-2):1-16. PubMed ID: 10327209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability of human immunodeficiency virus-1 in the female genital reservoir during genital reactivation of herpes simplex virus type 2.
    LeGoff J; Roques P; Jenabian MA; Charpentier C; Brochier C; Bouhlal H; Gresenguet G; Frost E; Pepin J; Mayaud P; Belec L;
    Clin Microbiol Infect; 2015 Sep; 21(9):873.e1-9. PubMed ID: 26003280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-subtype T-cell immune responses induced by a human immunodeficiency virus type 1 group m consensus env immunogen.
    Weaver EA; Lu Z; Camacho ZT; Moukdar F; Liao HX; Ma BJ; Muldoon M; Theiler J; Nabel GJ; Letvin NL; Korber BT; Hahn BH; Haynes BF; Gao F
    J Virol; 2006 Jul; 80(14):6745-56. PubMed ID: 16809280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombination estimation under complex evolutionary models with the coalescent composite-likelihood method.
    Carvajal-Rodríguez A; Crandall KA; Posada D
    Mol Biol Evol; 2006 Apr; 23(4):817-27. PubMed ID: 16452117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity testing of a novel engineered HIV-1 envelope gp140 DNA vaccine construct.
    Kumar S; Yan J; Muthumani K; Ramanathan MP; Yoon H; Pavlakis GN; Felber BK; Sidhu M; Boyer JD; Weiner DB
    DNA Cell Biol; 2006 Jul; 25(7):383-92. PubMed ID: 16848679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease progression and evolution of the HIV-1 env gene in 24 infected infants.
    Carvajal-Rodríguez A; Posada D; Pérez-Losada M; Keller E; Abrams EJ; Viscidi RP; Crandall KA
    Infect Genet Evol; 2008 Mar; 8(2):110-20. PubMed ID: 18249158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the V3 region of HIV-1 isolates from Sydney, Australia.
    Distler O; McQueen PW; Tsang ML; Byrne C; Neilan BA; Evans L; Penny R; Cooper DA; Delaney SF
    AIDS Res Hum Retroviruses; 1995 Mar; 11(3):423-5. PubMed ID: 7786588
    [No Abstract]   [Full Text] [Related]  

  • 14. Semen-specific genetic characteristics of human immunodeficiency virus type 1 env.
    Pillai SK; Good B; Pond SK; Wong JK; Strain MC; Richman DD; Smith DM
    J Virol; 2005 Feb; 79(3):1734-42. PubMed ID: 15650198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An abnormally long HIV-1 env DNA PCR product due to altered sequences of primer binding sites.
    Boriskin YS; Sharland M; Booth JC
    New Microbiol; 1999 Jan; 22(1):59-62. PubMed ID: 10190118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the key to a successful HIV type 1 vaccine lie among the envelope sequences of infected individuals?
    Rencher SD; Slobod KS; Dawson DH; Lockey TD; Hurwitz JL
    AIDS Res Hum Retroviruses; 1995 Sep; 11(9):1131-3. PubMed ID: 8554911
    [No Abstract]   [Full Text] [Related]  

  • 17. The population genetics of dN/dS.
    Kryazhimskiy S; Plotkin JB
    PLoS Genet; 2008 Dec; 4(12):e1000304. PubMed ID: 19081788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for heterogeneous selective pressures in the evolution of the env gene in different human immunodeficiency virus type 1 subtypes.
    Travers SA; O'Connell MJ; McCormack GP; McInerney JO
    J Virol; 2005 Feb; 79(3):1836-41. PubMed ID: 15650207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral variability and serum antibody response in a laboratory worker infected with HIV type 1 (HTLV type IIIB).
    Reitz MS; Hall L; Robert-Guroff M; Lautenberger J; Hahn BM; Shaw GM; Kong LI; Weiss SH; Waters D; Gallo RC
    AIDS Res Hum Retroviruses; 1994 Sep; 10(9):1143-55. PubMed ID: 7826699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diversity considerations in HIV-1 vaccine selection.
    Gaschen B; Taylor J; Yusim K; Foley B; Gao F; Lang D; Novitsky V; Haynes B; Hahn BH; Bhattacharya T; Korber B
    Science; 2002 Jun; 296(5577):2354-60. PubMed ID: 12089434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.